Notice of Effectiveness · EFFECT
Equillium, Inc.
EQNASDAQEQUITYCurrent
Notice of Effectiveness
Structured filing — EFFECT
primary_doc.xml
Notice details
- Submission type
- EFFECT
- Act
- 33
Effectiveness
- Effective date
- 2026-11-19
- Effective time (as filed)
- 16:00:00
- Form
- S-3
Registrant 1
- Registrant
- Equillium, Inc.
- Registrant CIK
- 0001746466
- File number
- 333-300003
Company context
Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat serious autoimmune and inflammatory disorders. For more information, visit www.equilliumbio.com.